SERETIDE 50/500mcg Versus Tiotropium Bromide On Exacerbation Rates In Severe Chronic Obstructive Pulmonary Disease
Status:
Completed
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
This is a comparator study to assess the relative efficacy of the combination product
fluticasone propionate/salmeterol 50/500 and tiotropium bromide on the rate of exacerbations
of chronic obstructive pulmonary disease (COPD) over a two year study interval.